Role of the pro-survival molecule Bfl-1 in melanoma
- PMID: 25486183
- DOI: 10.1016/j.biocel.2014.11.015
Role of the pro-survival molecule Bfl-1 in melanoma
Abstract
Bfl-1 is a pro-survival Bcl-2 family member overexpressed in a subset of chemoresistant tumours, including melanoma. Here, we characterised the expression and regulation of Bfl-1 in normal and malignant melanocytes and determined its role in protecting these cells from chemotherapy-induced apoptosis. Bfl-1 was mitochondrially resident in both resting and apoptotic cells and experienced regulation by the proteasome and NFκB pathways. siRNA-mediated knockdown enhanced sensitivity towards various relevant drug treatments, with forced overexpression of Bfl-1 protective. These findings identify Bfl-1 as a contributor towards therapeutic resistance in melanoma cells and support the use of NFκB inhibitors alongside current treatment strategies.
Keywords: Apoptosis; BCL2A1; Bfl-1; Melanocytes; Melanoma.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma.Blood. 2010 Apr 29;115(17):3559-69. doi: 10.1182/blood-2009-08-236760. Epub 2010 Feb 25. Blood. 2010. PMID: 20185581 Free PMC article.
-
BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4321-6. doi: 10.1073/pnas.1205575110. Epub 2013 Feb 27. Proc Natl Acad Sci U S A. 2013. PMID: 23447565 Free PMC article.
-
Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.Pigment Cell Melanoma Res. 2008 Oct;21(5):534-44. doi: 10.1111/j.1755-148X.2008.00491.x. Epub 2007 Jul 28. Pigment Cell Melanoma Res. 2008. PMID: 18715233 Free PMC article.
-
Molecular pathogenesis of cutaneous melanocytic neoplasms.Annu Rev Pathol. 2009;4:551-79. doi: 10.1146/annurev.pathol.3.121806.151541. Annu Rev Pathol. 2009. PMID: 19400696 Review.
-
BCL2A1: the underdog in the BCL2 family.Cell Death Differ. 2012 Jan;19(1):67-74. doi: 10.1038/cdd.2011.158. Epub 2011 Nov 11. Cell Death Differ. 2012. PMID: 22075983 Free PMC article. Review.
Cited by
-
Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy.Int J Mol Sci. 2018 Dec 8;19(12):3950. doi: 10.3390/ijms19123950. Int J Mol Sci. 2018. PMID: 30544835 Free PMC article. Review.
-
Chk1 inhibitor-induced DNA damage increases BFL1 and decreases BIM but does not protect human cancer cell lines from Chk1 inhibitor-induced apoptosis.Am J Cancer Res. 2022 May 15;12(5):2293-2309. eCollection 2022. Am J Cancer Res. 2022. PMID: 35693081 Free PMC article.
-
Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins.J Med Chem. 2020 Mar 12;63(5):2489-2510. doi: 10.1021/acs.jmedchem.9b01442. Epub 2020 Feb 14. J Med Chem. 2020. PMID: 31971799 Free PMC article.
-
Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors.Cell Chem Biol. 2016 Sep 22;23(9):1123-1134. doi: 10.1016/j.chembiol.2016.07.022. Epub 2016 Sep 8. Cell Chem Biol. 2016. PMID: 27617850 Free PMC article.
-
TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1.Cell Death Differ. 2019 May;26(5):902-917. doi: 10.1038/s41418-018-0169-5. Epub 2018 Jul 24. Cell Death Differ. 2019. PMID: 30042493 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
